Dividend payout received ✅

After reaching its all-time high in August, ASR’s share price has pulled back by about 10%. At this level, I see it as an excellent buying opportunity, given the company’s solid fundamentals and strong financial position. ASR has consistently delivered value to its investors, and I believe it is well-positioned to continue doing so in the long run.

I recently took advantage of this dip by adding 10 more shares to my position, bringing my total holdings to 35. I’m confident that patience will be rewarded as the company continues to generate stable growth and reliable returns.

So I just realised that I've been investing for exactly 1 year and 1 week, so I thought this would be a good moment to reflect. I'm 36, the total portfolio size is 50k+ and the money isn't needed in short term. My portfolio summarised:

1. ETF core, 50% at minimum: $VDEV (+0,22%) and $VFEM (+0,56%) , recently added $EUE (-0,02%) as I see more potential in the EU than in the US in the short-medium term. I like how a combination of these 3 ETFs allows for more adaptability than simply putting everything in a world ETF. Plus, the TER is a bit lower.

2. Individual stocks, max 10 positions, only including companies that I understand and have faith in that they will perform well in the next couple of years. The goal is to at least match $IWDA (+0,25%) but preferably to make some additional gains. In summary:

Tech:

$NVDA (-0,35%) : committed after the post-Deepseek dip, will just wait out all the short-term turbulence

$AMZN (+0,3%) : doesn't need additional info.

$ASML (-0,65%) : ditto

$VRT (+3,49%) : see one of my previous posts on GQ. Bit too volatile for me now, but when the AI-hype picks up again, will perform well.

Health:

$NVO (-0,12%) : I have a lot of faith in the GLP1-narrative, stock is very undervalued

$LLY (-0,33%) : same at NVO, got pummeled hard recently but in longer term another good bet in the GLP1-race.

Divident:

$ALV (+0,18%) : popular German insurance company. Divident-wise, I have more faith in insurance companies than banks. Banks also face more headwinds due to fintech.

$ASRNL (+0,21%) : comparable to Allianz, solid, no-nonsense Dutch insurance company.

Bit more speculative:

$NU (-4,73%) : I think fintech has a lot of potential and NU was valued quite cheaply compared to US- or EU-based counterparts. Could benefit from US recession if USD evaluates.

What are your thoughts? What would you add or lose? I'm thinking of adding $GOOG (+0,91%) when the current downtrend subsides. Does make the portfolio more tech-heavy but all companies are internationally oriented (in case of US recession) and should outperform in the longer term.

Thanks in advance!

bought another 30 asr shares today. perhaps already a bit overpriced, but still a very attractive dividend growth share. soon a good cash flow and buy dividends again and reinvest nicely. can't wait :)

New weekly update, without purchase, but with most important data for me from the results of $ASRNL (+0,21%) and $NN (-1,09%)

$NN (-1,09%)

$ASRNL (+0,21%)
#dividends
#investing
#dividend
#investment
#stocks

https://youtu.be/WTl-Sj8plX4

Great results from $NN (-1,09%)

8% dividend increase and a 300 million share buyback program

$NN (-1,09%)
$ASRNL (+0,21%)
$AGN

#nngroup
#dividend
#investing
#dividends
#stock